InvestSMART

Nuheara Limited (ASX: NUH) - Announcements

DELISTED - Current share price for NUH : $0.081

ASX company news and announcements for Nuheara Limited (NUH) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Nuheara Limited (NUH) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Nuheara Limited (NUH), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Nuheara Limited (NUH)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
- NUH Appointed Service Provider to Fed Govt Hearing Program 3 Nov 2021 9:19AM $0.021 $0.081 risen by 285.71%
- 2022FY Q1 Results 27 Oct 2021 12:26PM $0.022 $0.081 risen by 268.18%
- Quarterly Activities Report and Appendix 4C 27 Oct 2021 9:42AM $0.024 $0.081 risen by 237.50%
- Q1 FY22 Business Update and Investor Briefing Details 26 Oct 2021 8:28AM $0.024 $0.081 risen by 237.50%
- Jobkeeper Payments Notice 22 Oct 2021 6:02PM $0.023 $0.081 risen by 252.17%
- US FDA Issues Landmark Proposal for OTC Hearing Aids 21 Oct 2021 9:59AM $0.025 $0.081 risen by 224%
- NUH Commences Clinical Trial with Pathway to FDA Submission 15 Oct 2021 9:38AM $0.025 $0.081 risen by 224%
- Results of Meeting 14 Oct 2021 4:02PM $0.024 $0.081 risen by 237.50%
- 2021 Annual General Meeting Presentation 14 Oct 2021 1:41PM $0.024 $0.081 risen by 237.50%
- Application for quotation of securities - NUH 5 Oct 2021 8:24PM $0.027 $0.081 risen by 200%
- Notification of cessation of securities - NUH 5 Oct 2021 8:21PM $0.027 $0.081 risen by 200%
- Change in substantial holding 24 Sep 2021 3:30PM $0.029 $0.081 risen by 179.31%
- NUH to Present at Kepler Cheuvreux Hearing Aid Investor Days 21 Sep 2021 8:21AM $0.027 $0.081 risen by 200%
- Nuheara Receives Ethics Approval To Commence Clinical Trial 15 Sep 2021 8:51AM $0.030 $0.081 risen by 170%
- Letter to Shareholders - Notice of Annual General Meeting 10 Sep 2021 8:41AM $0.029 $0.081 risen by 179.31%
- Notice of Annual General Meeting/Proxy Form 10 Sep 2021 8:39AM $0.029 $0.081 risen by 179.31%
- Notification of cessation of securities - NUH 2 Sep 2021 7:10PM $0.032 $0.081 risen by 153.13%
- Notification regarding unquoted securities - NUH 2 Sep 2021 7:10PM $0.032 $0.081 risen by 153.13%
- Application for quotation of securities - NUH 2 Sep 2021 6:52PM $0.032 $0.081 risen by 153.13%
- 2021 Annual General Meeting - Key Dates 19 Aug 2021 7:08PM $0.036 $0.081 risen by 125%
- Presentation - 2021FY Results 18 Aug 2021 8:45AM $0.034 $0.081 risen by 138.24%
- Appendix 4E & Annual Report for the Year Ended 30 June 2021 18 Aug 2021 8:34AM $0.034 $0.081 risen by 138.24%
- Appendix 4G and Corporate Governance Statement 18 Aug 2021 8:29AM $0.034 $0.081 risen by 138.24%
- Nuheara to Commence Medical Device Clinical Trial 17 Aug 2021 9:24AM $0.034 $0.081 risen by 138.24%
- Trading Halt 13 Aug 2021 10:11AM $0.034 $0.081 risen by 138.24%

226 - 250 of 620 results

Page 10 of 25

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.